Raymond James upgrades Lumentum stock rating on Marvell deal value
Raymond James upgraded Lumentum (LITE) to Strong Buy, raising its price target to $1,328. The firm believes the market reaction to Lumentum's pre-announcement and Marvell acquisition was overdone. Lumentum reported Q1 2027 revenue of $1.26B and EPS of $4.57, beating guidance. The company agreed to merge with Marvell in an all-stock deal, with analysts citing both potential benefits and risks.
How this was made
The 30-second read
Why it matters
Analyst upgrades and downgrades directly affect short‑term price expectations and may influence investor positioning ahead of the merger completion.
Market read
The analyst actions provide fresh price targets and sentiment shifts for both Lumentum and Marvell, creating actionable trading signals.
What to watch
Potential regulatory scrutiny of the all‑stock merger and execution risk of scaling Lumentum's capacity through 2029.
Background
The article reports recent analyst actions surrounding the pending Lumentum‑Marvell acquisition, including a Strong Buy upgrade for Lumentum and a target cut for Marvell.
Ticker impact
Raymond James upgraded Lumentum Holdings to Strong Buy and raised its price target to $1,328, citing the Marvell acquisition as undervalued.
likely upward pressure as investors price in the higher target and acquisition synergies.
Analyst upgrade with a concrete new target provides a clear catalyst for buying interest.
B. Riley cut Marvell Technology's price target to $275, citing dilution and integration risks from the pending Lumentum deal.
potential pressure as the market absorbs dilution concerns and lower target.
Analyst downgrade with a specific target change creates a near‑term bearish catalyst.
Market effects
AI optics and semiconductor sectors may see valuation adjustments as the Lumentum‑Marvell deal is re‑priced.
U.S. tech stocks could experience modest volatility in response to the analyst revisions.
Limited to semiconductor supply chain participants; no broad macro impact.
Counterpoint
The upgrade may be premature if integration risks materialize, keeping the stock vulnerable to downside.
Key entities
- analyst_firmRaymond James
Upgraded Lumentum to Strong Buy and raised its price target.
- analyst_firmB. Riley
Reduced Marvell's price target citing dilution concerns.

